EQS-Adhoc: IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05

EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Research Update/Research Update

IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND …

EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Research Update/Research Update
IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND ...